Influence of times of CIK cell treatment on survival of elderly patients with gastric cancer
10.3760/cma.j.issn.0254-9026.2010.06.018
- VernacularTitle:细胞因子诱导的杀伤细胞治疗老年人胃癌的次数对其生存期的影响
- Author:
Jingting JIANG
;
Changping WU
;
Yueping SHEN
;
Binfeng LU
;
Xueguang ZHANG
- Publication Type:Journal Article
- Keywords:
Stomach neoplasm;
Killer cells;
Immunotherapy,adoptive;
Survival rate
- From:
Chinese Journal of Geriatrics
2010;29(6):502-505
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the relevance between the times of cytokine-induced killer cell (CIK cell) adoptive immunotherapy and the survival of the elderly patients with gastric cancer.Methods Lymphocyte separation medium was used to isolate mononuclear cells, and then the cultured CIK cells were infused back into the patients with gastric cancer. A retrospective cohort study was adopted by using Kaplan-Meier to estimate median survival time and survival rate, using Log-rank test to analyze the impact of clinical factors on survival rate, and using RR and 95% CI to estimate the contact intensity of death outcome, survival time and CIK cell treatment. Results There were nostatistically significant differences in gender,age, tumor site, histological type, invasion depth, lymph node metastasis, pathological grade, tumor size or tumor distribution between chemotherapy group and CIK treatment group (all P＞0.05). The median survival time of patients with gastric cancer was significantly longer in CIK treatment group than in chemotherapy group (61 vs. 21, χ2=10.215, P=0.001). Compared with the patients treated by chemotherapy alone, the increased times of CIK treatment induced more survival rate and 2-5 years life spans (χ2=12. 461, P=0.006). Conclusions With the treatment that CIK cells are infused back into the elderly patients with gastric cancer, the risk of death is reduced, and the lifespan is prolonged, which is associated with the CIK cell treatment times.
